this is all the detail hopefully they'll have in their next announcement.
We've known for sometime approx/potential pricing/where it'll sit compared to the competition.....but by now they will have locked in pricing/insurers cover etc.
All this I'm sure will be in the next announcement......+ update on how the patient experience program is running/configured & to whom gets to be involved. (will they just be people associated with the Hyperhidrosis Society data base)?
Maybe an update on resourcing sales people etc.
Sure - it's a little hard waiting to hear since we had approval back in June 20.......but patience is needed. Realistically, what else could they have announced since that they haven't already told us?
It's only now we are seeing SOFDRA pop up on US pharmacy websites.....clearly they have hit the ground running like they said they would.
I'm sure (like they said mid Aug) - an announcement imminent.
Very exciting times!!
BOT - Anything but charting, page-9719
-
- There are more pages in this discussion • 1,687 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $645.1M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.5¢ | 34.3¢ | $1.009M | 2.889M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 183450 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 274797 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |